https://www.selleckchem.com/pr....oducts/leupeptin-hem
ng and treatment outcomes. To analyze prefrailty's relationship with limitations in activities of daily living (ADLs) and restrictions in social participation. Robust (Fried 0/4; = 214; = 82.3 years [ ±2.1]) and prefrail (Fried 1-2/4; = 191; = 83.8 years [ ±3.2]) community-dwelling older individuals were included. Frailty scores were obtained from weight loss, exhaustion, gait speed, and grip strength. A total disability index (DI) expressed dependency for basic (b-), instrumental (i-), and advanced (a-)ADLs. Total partici